Jam

  • Impact Silver Announces Q1 2025 Results: Revenue Nearly Doubles, EBITDA Reaches $1.0 Million

    IMPACT Silver reported a strong Q1 2025, with revenue doubling to $10.7 million, driven by Plomosas mine production and favorable prices. The company achieved positive EBITDA of $1.0 million and narrowed its net loss. Increased ore processing and silver production were also highlights. The company plans a $5 million equity financing and focuses on expanding zinc and gold production.

    2025年5月27日
  • SciSparc Announces Japanese Patent Application Publication

    SciSparc Ltd. announced a Japanese patent application for a novel pain management therapy. The application covers a combination of paracetamol and palmitoylethanolamide (PEA) designed to enhance pain and fever relief while potentially reducing side effects, including liver damage. This synergistic approach aims to improve treatment outcomes for various pain types and leverage the body’s endocannabinoid system.

    2025年5月27日
  • WeRide Launches Robotaxis and More Autonomous Driving Solutions in Saudi Arabia

    WeRide is expanding into Saudi Arabia, launching Robotaxis and other autonomous vehicle products in Riyadh and AlUla, with trial runs on Uber soon and full commercial services expected by late 2025. The move includes Robobuses and Robosweepers, aligning with Saudi Vision 2030. This strategic expansion builds upon WeRide’s existing Middle East presence and complements Uber’s global expansion. Key advantages are a multi-product strategy catering diverse needs and aligning with ambitious regional goals.

    2025年5月27日
  • Premium Drilling Extends Mineralization 315 Meters Below Resource Area, Indicating Scalable Expansion at the Selebi Project

    Premium Resources Ltd. announced significant mineralization expansion at its Selebi North Underground project in Botswana. Recent drilling extended the South Limb mineralization by 315 meters beyond the current resource boundaries, with one hole intersecting mineralization over 16.20 meters. BHEM surveys suggest potential for further resource expansion. Assay results are expected in July. The existing resource shows strong grades exceeding 3% CuEq.

    2025年5月27日
  • ACI Worldwide Reshapes Payments with ACI Connetic

    ACI Worldwide launched ACI Connetic, a new cloud-native payment hub integrating various global payment networks. This platform brings together account-to-account, card payments, and AI-driven fraud prevention, allowing financial institutions to modernize payment infrastructures. Designed for scalability and resilience, ACI Connetic aims to streamline operations, reduce costs, and accelerate innovation. The solution, which is gaining traction in Europe and the US, will be showcased at EBAday 2025.

    2025年5月27日
  • JOYY Announces Q1 2025 Earnings: Non-Livestream Revenue Up 25.3% Year-Over-Year

    JOYY Inc. reported strong Q1 2025 results, showcasing revenue of $494.4 million. Non-livestreaming revenue surged 25.3% year-over-year, representing 24.9% of total revenue. Significant growth was observed in both GAAP and non-GAAP operating profit, with operational efficiency reflected in operating margins. The company also returned value to shareholders through dividends and share repurchases, and is focusing on diversification through core livestreaming and the expanding BIGO Ads platform.

    2025年5月27日
  • Animon.ai, AI-Powered Anime Video Platform, Launches in Korea

    CreateAI launched its AI-powered anime platform, Animon.ai, in Korea, following its Japan debut. The platform features text-to-video generation, expanded language support (including Traditional Chinese and Korean), and a subscription model for unlimited content creation. Developed with leading Japanese animators, Animon.ai aims to empower creators with user-friendly, professional-grade tools and a straightforward “text → image → video” workflow, with plans for further feature and language expansion.

    2025年5月27日
  • JOYY Reports First Quarter 2025 Financial Results (Unaudited)

    JOYY Inc. (NASDAQ: JOYY) reported mixed Q1 2025 results, with lower overall revenue but improved profitability driven by diversification and cost management. Non-livestreaming revenue surged. The company returned capital to shareholders via dividends and share repurchases. User metrics showed declines, but net cash remains strong. JOYY forecasts revenue growth for Q2, emphasizing its strategic shift and diversified business model, particularly in advertising.

    2025年5月27日
  • Silvercorp Declares Semi-Annual Dividend of US$0.0125 per Share

    Silvercorp Metals Inc. (TSX: SVM; NYSE American: SVM) declared a semi-annual cash dividend of US$0.0125 per common share, payable by June 26, 2025, to shareholders of record as of June 6. The Canadian precious metals producer highlighted the dividend’s eligibility for favorable tax treatment under Canadian regulations, reflecting confidence in its operational stability amid volatile silver prices (US$28–34/oz this quarter). With 14 consecutive years of positive cash flow, Silvercorp has distributed over US$145 million to shareholders since 2011 through dividends and buybacks. The company’s shares rose 18% YTD, outperforming peers, while its strategy emphasizes low-cost mining, exploration, strategic acquisitions, and ESG integration across global operations.

    2025年5月26日
  • Alvotech Schedules Annual General Meeting for June 25, 2025

    Alvotech (NASDAQ: ALVO) will hold its 2025 Annual General Meeting on June 25 in Reykjavik, with virtual access available. Shareholders will review governance updates, financial results, and strategies to bolster its position in the biosimilars market, projected to yield $50 billion in global savings by 2027. Key discussions include expanding its biosimilar pipeline, regulatory progress in the U.S. and Europe, and addressing pricing challenges and patent cliffs. Analysts highlight priorities like commercial partnerships, scalable manufacturing, and differentiation in immunology and oncology. The meeting may signal strategic shifts as Alvotech navigates evolving FDA regulations and leverages biosimilars to counter pharmaceutical revenue declines, emphasizing speed-to-market and cost efficiency.

    2025年5月26日